PROTEOSTASIS THERAPEUTICS, INC. License Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AMENDED AND RESTATED LICENSE AGREEMENT
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2015
Fourth Amendment to Option and License Agreement (CD27), dated as of December 14, 2023, by and between Gigagen, Inc. and Kineta, Inc
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Second Amendment to Option and License Agreement (CD27), dated as of December 21, 2022, by and between Gigagen, Inc. and the Company
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Third Amendment to Option and License Agreement (CD27), dated as of May 25, 2023, by and between Gigagen, Inc. and Kineta, Inc
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
Second Amendment to Option and License Agreement (VISTA), dated as of May 25, 2023, by and between Gigagen, Inc. and Kineta, Inc
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
2023
License Agreement by and between Yumanity Therapeutics, Inc. and MIL 40, LLC dated as of February 28, 2022
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2022
License Agreement, by and between Yumanity Therapeutics, Inc. and MIL 40G LLC, dated as of February 5, 2020
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
Tangible Property and Exclusive Patent License Agreement, by and between Yumanity Therapeutics, Inc., Yumanity Holdings, LLC and Whitehead Institute for Biomedical Research, dated...
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2020
Technology Transfer and License Agreement between the Company and Genentech, Inc., dated December 13, 2018
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2019
COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BY AND BETWEEN PROTEOSTASIS THERAPEUTICS, INC. and BIOGEN IDEC NEWVENTURES INC. December 5, 2013
License Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
MA
2015